PMID: 6108449Dec 13, 1980Paper

Aminoacid therapy of alcoholic hepatitis

Lancet
S M Nasrallah, J T Galambos

Abstract

35 consecutive patients with alcoholic hepatitis were randomly allocated to control (18 patients) and study (17 patients) groups. All patients were offered a 3000 kcal 100 g protein diet and were studied for 28 days. The study group received 70-85 g of intravenous aminoacids daily in the form of 'Aminosyn' or 'Travasol'. Both groups had similar clinical and biochemical features at the time of randomisation. Ascites and encephalopathy tended to improve more in the study group. Serum concentrations of bilirubin (p < 0.01) and albumin (p < 0.025) improved in the study but not in the control group. 4 patients died in the control group, but none died in the study group. Intravenous therapy with aminoacid for 4 weeks seemed to be associated with lower mortality rate (p < 0.02) and improved serum bilirubin and albumin concentrations in patients with alcoholic hepatitis.

Citations

Jun 1, 1984·Digestive Diseases and Sciences·R L Koretz
Jul 1, 1990·Digestive Diseases and Sciences·M NissenbaumP Gartside
May 15, 1984·The American Journal of Medicine·J A Tayek, G L Blackburn
Mar 1, 1984·Alcohol·C S Lieber
Jan 1, 1989·Baillière's Clinical Gastroenterology·J B Saunders
Sep 1, 1993·Baillière's Clinical Gastroenterology·M J RamondJ P Benhamou
Jun 1, 1997·Disease-a-month : DM·B A Mizock, S Troglia
Feb 25, 1984·Lancet·S Sherlock
Feb 20, 2003·Journal of Hepatology·Stephen F Stewart, Christopher P Day
Jul 1, 1997·Journal of Hepatology·J Kondrup, M J Müller
Dec 17, 2003·Journal of Gastroenterology and Hepatology·Paul S HaberGeoffrey W McCaughan
Aug 13, 1981·The New England Journal of Medicine
Jan 2, 1997·The New England Journal of Medicine·W W Souba
Jul 29, 2005·The Proceedings of the Nutrition Society·Ronald L Koretz
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·W C Maddrey
Jan 1, 1985·Alcoholism, Clinical and Experimental Research·D Frank, R F Raicht
Jul 1, 1995·São Paulo Medical Journal = Revista Paulista De Medicina·O M ParraW A Saad Junior
May 26, 2007·Journal of the American Dietetic Association·Ronald L Koretz
Sep 1, 1985·JPEN. Journal of Parenteral and Enteral Nutrition·D R Antonow, C J McClain
May 1, 1983·JPEN. Journal of Parenteral and Enteral Nutrition
May 1, 1991·JPEN. Journal of Parenteral and Enteral Nutrition·L Marsano, C J McClain
Mar 1, 1993·JPEN. Journal of Parenteral and Enteral Nutrition·S HirschG Ugarte
Sep 1, 1988·JPEN. Journal of Parenteral and Enteral Nutrition·M J GlynnI M Murray-Lyon
Jan 1, 1992·Gastroenterology·P J KearnsP Gregory
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E CabréM A Gassull
May 18, 2012·The Cochrane Database of Systematic Reviews·Ronald L KoretzTimothy O Lipman
Apr 4, 2017·The Cochrane Database of Systematic Reviews·Elena BuzzettiKurinchi Selvan Gurusamy
Sep 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W C Maddrey
Jun 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F L WeberS G Kelsen
Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T R Morgan, C L Mendenhall
Mar 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S NaveauJ C Chaput
Dec 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E MezeyJ Rodés
Jan 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Y MinukS K Kelly
Jan 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M DiehlE Mezey
Nov 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S SoberonC H Halsted
Feb 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D J Nompleggi, H L Bonkovsky
Nov 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F C FowlerM E Mailliard
Apr 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C L MendenhallJ I Allen
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S Schenker
Sep 30, 2009·The Mount Sinai Journal of Medicine, New York·Hui-Hui TanPaul Martin
Jan 1, 1992·Critical Reviews in Clinical Laboratory Sciences·S W French
Nov 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C S Lieber
Jan 1, 1989·Journal of the American College of Nutrition·B R Bistrian, T Jaksic
Jan 1, 1983·Journal of the American College of Nutrition·F N Homsy, G L Blackburn
Apr 1, 1995·Journal of the American College of Nutrition·T R MorganR Haas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.